Clinical Trials Directory

Trials / Sponsors / Presage Biosciences

Presage Biosciences

Industry · 9 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingPBI-MST-01 (NCT04541108) Substudy AZN-05: Intratumoral Microdosing of Rilvegostomig, Volrustomig, Sabestomig,
Head and Neck Squamous Cell Carcinoma
EARLY_Phase 12024-05-22
CompletedPBI-MST-01 (NCT04541108) Substudy MSD-03: Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or
Head and Neck Squamous Cell Carcinoma, Soft Tissue Sarcoma
EARLY_Phase 12022-06-01
TerminatedIntratumoral Microdosing of Motolimod in HNSCC
HNSCC
EARLY_Phase 12021-10-15
WithdrawnCIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia
Solid Tumour
EARLY_Phase 12021-09-15
CompletedPBI-MST-01(NCT04541108) Substudy TAK-02: Intratumoral Microdosing of TAK-676 in HNSCC
Head and Neck Squamous Cell Carcinoma
EARLY_Phase 12021-07-26
RecruitingPhase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies
Solid Tumor
EARLY_Phase 12021-07-26
CompletedIntratumoral Microdosing of TAK-981 in Head and Neck Cancer
Head and Neck Cancer
EARLY_Phase 12020-10-07
CompletedPrecise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma
Soft Tissue Sarcoma Adult
Phase 12016-12-15
CompletedFeasibility of Assessing Lymphoma Response to Precise Local Injection of Candidate Chemotherapy Agents
Lymphoma
Phase 12012-11-01